DeepMed Research

BOSTON MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1996-01-01

Employees: 1K

Market Cap: -

Website: http://www.bmc.org

Clinical Trials

Otiprio Versus Ciprodex Tympanostomy Tube Outcomes

Phase 4

Withdrawn

Conditions: Otorrhea
Otitis Media With Effusion in Children

Interventions: Drug: Otiprio
Drug: Ciprodex

First Posted Date: 2017-11-20

Last Posted Date: 2018-09-14

Lead Sponsor: Boston Medical Center

Registration Number: NCT03347461

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

Platysma Incision Cosmesis

Not Applicable

Completed

Conditions: Wound Heal

Interventions: Procedure: Anterior Cervical Decompression and Fusion
Procedure: Vertical Platysma Incision
Procedure: Transverse Platysma Incision

First Posted Date: 2017-11-09

Last Posted Date: 2020-07-07

Lead Sponsor: Boston Medical Center

Target Recruit Count: 22

Registration Number: NCT03338608

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

Linking Infectious and Narcology Care-Part II

Phase 4

Completed

Conditions: HIV Infection
Drug Use

Interventions: Other: Rapid ART initiation
Drug: Pharmacotherapy for opioid use disorder
Behavioral: Strengths-based HIV case management

First Posted Date: 2017-09-21

Last Posted Date: 2023-04-18

Lead Sponsor: Boston Medical Center

Target Recruit Count: 225

Registration Number: NCT03290391

Locations: 🇷🇺
First St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation
🇷🇺
City Addiction Hospital, St. Petersburg, Russian Federation

St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene

Phase 1

Completed

Conditions: HIV Infection
Alcohol Use
Pain

Interventions: Drug: Low dose naltrexone
Drug: Nalmefene

First Posted Date: 2017-09-12

Last Posted Date: 2020-08-24

Lead Sponsor: Boston Medical Center

Target Recruit Count: 11

Registration Number: NCT03278886

Locations: 🇷🇺
First St. Petersburg Pavlov State Medical University, St. Petersburg, Russian Federation

Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers

Phase 1

Completed

Conditions: Alcohol Use Disorder

Interventions: Drug: Placebo oral capsule
Drug: Lacosamide

First Posted Date: 2017-09-05

Last Posted Date: 2021-06-03

Lead Sponsor: Boston Medical Center

Target Recruit Count: 66

Registration Number: NCT03271528

Locations: 🇺🇸
Boston University Psychiatry Research Center, Clinical Studies Unit, Boston, Massachusetts, United States

Relaxation Breathing Training for Children

Not Applicable

Withdrawn

Conditions: Biofeedback
Stress Disorder

Interventions: Behavioral: The StressEraser
Behavioral: Breathe2Relax
Behavioral: Reminder text messages

First Posted Date: 2017-09-01

Last Posted Date: 2020-11-17

Lead Sponsor: Boston Medical Center

Registration Number: NCT03271086

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

Patient Navigation in Cancer Survivorship at a Safety Net Institution

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Navigator

First Posted Date: 2017-09-01

Last Posted Date: 2021-09-08

Lead Sponsor: Boston Medical Center

Target Recruit Count: 39

Registration Number: NCT03271099

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

Multimodal Outcome CHAracterization in Comatose Cardiac Arrest Patients Registry and Tissue Repository

Recruiting

Conditions: Cardiac Arrest

First Posted Date: 2017-08-24

Last Posted Date: 2024-12-27

Lead Sponsor: Boston Medical Center

Target Recruit Count: 600

Registration Number: NCT03261089

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

Secondary Prevention of Atrial Fibrilation

Not Applicable

Terminated

Conditions: Risk Factors
Atrial Fibrillation
Risk Reduction Behavior

Interventions: Other: AliveCor mobile ECG cardiac monitor
Other: Standard of care
Behavioral: AF Program

First Posted Date: 2017-08-24

Last Posted Date: 2021-01-26

Lead Sponsor: Boston Medical Center

Target Recruit Count: 3

Registration Number: NCT03259893

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

Oral Versus Intravenous Sedation for Ocular Procedures

Phase 4

Completed

Conditions: Surgery
Sedation

Interventions: Drug: Triazolam
Drug: Midazolam
Drug: Microcrystalline Cellulose
Drug: Sodium chloride 0.9%

First Posted Date: 2017-08-11

Last Posted Date: 2020-08-19

Lead Sponsor: Boston Medical Center

Target Recruit Count: 327

Registration Number: NCT03246724

Locations: 🇺🇸
Boston Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy